Model
Edge
Amarantus Bioscience Holdings Inc.
0001424812
Filing Type
1-A
Filing Date
9/26/2019
Updated
9/27/19, 9:45 AM
Copy Ref
Filing
1-A
Earnings Release
Exhibits
1-A
Offering Statement
PART II AND III
AMENDMENT NO.1 TO DRAFT OFFERING CIRCULAR
EX1A-2A CHARTER
CERTIFICATE OF DESIGNATION SERIES A
EX1A-2A CHARTER
CERTIFICATE OF DESIGNATION SERIES B
EX1A-2A CHARTER
CERTIFICATE OF DESIGNATION SERIES C
EX1A-2A CHARTER
CERTIFICATEOF DESIGNATION SERIES D
EX1A-2A CHARTER
CERTIFICATE OF DESIGNATION SERIES E
EX1A-6 MAT CTRCT
ELTOPRAZINE 3RD PARTY VALUATION IN PARKINSON'S LID
EX1A-6 MAT CTRCT
ESS 3RD PARTY VALUATION IN PARKINSON'S LID
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic